N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide

C96H100N32O5S — CID 167577880

IUPACN-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide
SMILESCCC(=O)NCc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccccc3)ccc12)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)c1nccs1.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(C3CCCC3)ccc12)C(C)=O
InChIInChI=1S/C21H21N5O.C20H18N8OS.C20H25N5O.C18H19N7O.C17H17N7O/c1-3-26(13(2)27)12-18-24-19-16-10-9-15(14-7-5-4-6-8-14)11-17(16)23-21(22)20(19)25-18;1-2-28(20(29)19-22-7-8-30-19)10-15-25-16-12-4-3-11(13-5-6-23-27-13)9-14(12)24-18(21)17(16)26-15;1-3-25(12(2)26)11-17-23-18-15-9-8-14(13-6-4-5-7-13)10-16(15)22-20(21)19(18)24-17;1-3-25(10(2)26)9-15-22-16-12-5-4-11(13-6-7-20-24-13)8-14(12)21-18(19)17(16)23-15;1-2-14(25)19-8-13-22-15-10-4-3-9(11-5-6-20-24-11)7-12(10)21-17(18)16(15)23-13/h4-11H,3,12H2,1-2H3,(H2,22,23)(H,24,25);3-9H,2,10H2,1H3,(H2,21,24)(H,23,27)(H,25,26);8-10,13H,3-7,11H2,1-2H3,(H2,21,22)(H,23,24);4-8H,3,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23);3-7H,2,8H2,1H3,(H2,18,21)(H,19,25)(H,20,24)(H,22,23)
InChIKeyGTXWRHILBAQHKU-UHFFFAOYSA-N
MW1814.14 g/mol
LogP15.21
Rot. Bonds21

About N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide

N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide (PubChem CID 167577880) has the molecular formula C96H100N32O5S and a molecular weight of 1814.14 g/mol. Its IUPAC name is N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide.

Molecular Properties

Compound NameN-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide
PubChem CID167577880
Molecular FormulaC96H100N32O5S
Molecular Weight1814.14 g/mol
Exact Mass1812.83
IUPAC NameN-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide
SMILESCCC(=O)NCc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccccc3)ccc12)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)c1nccs1.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(C3CCCC3)ccc12)C(C)=O
InChIInChI=1S/C21H21N5O.C20H18N8OS.C20H25N5O.C18H19N7O.C17H17N7O/c1-3-26(13(2)27)12-18-24-19-16-10-9-15(14-7-5-4-6-8-14)11-17(16)23-21(22)20(19)25-18;1-2-28(20(29)19-22-7-8-30-19)10-15-25-16-12-4-3-11(13-5-6-23-27-13)9-14(12)24-18(21)17(16)26-15;1-3-25(12(2)26)11-17-23-18-15-9-8-14(13-6-4-5-7-13)10-16(15)22-20(21)19(18)24-17;1-3-25(10(2)26)9-15-22-16-12-5-4-11(13-6-7-20-24-13)8-14(12)21-18(19)17(16)23-15;1-2-14(25)19-8-13-22-15-10-4-3-9(11-5-6-20-24-11)7-12(10)21-17(18)16(15)23-13/h4-11H,3,12H2,1-2H3,(H2,22,23)(H,24,25);3-9H,2,10H2,1H3,(H2,21,24)(H,23,27)(H,25,26);8-10,13H,3-7,11H2,1-2H3,(H2,21,22)(H,23,24);4-8H,3,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23);3-7H,2,8H2,1H3,(H2,18,21)(H,19,25)(H,20,24)(H,22,23)
InChIKeyGTXWRHILBAQHKU-UHFFFAOYSA-N
XLogP15.21
TPSA547.22 Ų
H-Bond Donors14
H-Bond Acceptors25
Rotatable Bonds21
Heavy Atoms134
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001814.14
LogP ≤ 515.21
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1025

Analyze N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide?
The IUPAC name of N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide (CID 167577880) is N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide.
What is the SMILES notation for N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide?
The canonical SMILES for N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide is CCC(=O)NCc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccccc3)ccc12)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)c1nccs1.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(C3CCCC3)ccc12)C(C)=O.
What is the InChIKey of N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide?
The InChIKey is GTXWRHILBAQHKU-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H21N5O.C20H18N8OS.C20H25N5O.C18H19N7O.C17H17N7O/c1-3-26(13(2)27)12-18-24-19-16-10-9-15(14-7-5-4-6-8-14)11-17(16)23-21(22)20(19)25-18;1-2-28(20(29)19-22-7-8-30-19)10-15-25-16-12-4-3-11(13-5-6-23-27-13)9-14(12)24-18(21)17(16)26-15;1-3-25(12(2)26)11-17-23-18-15-9-8-14(13-6-4-5-7-13)10-16(15)22-20(21)19(18)24-17;1-3-25(10(2)26)9-15-22-16-12-5-4-11(13-6-7-20-24-13)8-14(12)21-18(19)17(16)23-15;1-2-14(25)19-8-13-22-15-10-4-3-9(11-5-6-20-24-11)7-12(10)21-17(18)16(15)23-13/h4-11H,3,12H2,1-2H3,(H2,22,23)(H,24,25);3-9H,2,10H2,1H3,(H2,21,24)(H,23,27)(H,25,26);8-10,13H,3-7,11H2,1-2H3,(H2,21,22)(H,23,24);4-8H,3,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23);3-7H,2,8H2,1H3,(H2,18,21)(H,19,25)(H,20,24)(H,22,23).
What are the key properties of N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide?
N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide has a molecular weight of 1814.14 g/mol, XLogP of 15.21, 21 rotatable bonds, 14 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-amino-7-cyclopentyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[(4-amino-7-phenyl-3H-imidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-1,3-thiazole-2-carboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]propanamide is sourced from PubChem (CID 167577880), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).